Status:
TERMINATED
Mometasone vs Budesonide in CRS With Polyposis
Lead Sponsor:
Université de Sherbrooke
Conditions:
Chronic Rhinosinusitis (Diagnosis), Nasal Polyposis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The principal objective is to compare the use of mometasone nasal spray to budesonide irrigations in patients suffering from CRSwNP who have never been operated.
Eligibility Criteria
Inclusion
- Diagnosis of chronic rhinosinusitis with nasal polyps
- Absence of active infection at start of study
Exclusion
- Diagnosis of chronic rhinosinusitis without nasal polyps
- Diagnosis of recurrent acute bacterial rhinosinusitis
- Previous sinus surgery (septal of inferior turbinate surgeries are not considered sinus surgeries)
- Cystic fibrosis or ciliary dyskinesia
- Allergy to corticosteroids
- Pregnant or lactating women
- Contra-indication to intranasal steroids
Key Trial Info
Start Date :
May 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2022
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT03323866
Start Date
May 1 2017
End Date
August 1 2022
Last Update
September 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Université de Sherbrooke
Sherbrooke, Quebec, Canada, J1H 5N4